Trend
DailyUptrend (confirmed)
4 hourAscending Triangle
1 hourBullish
15 minBullish
5 minNo data
Daily trend turns down below $134.02
Key levels
Support$134.88
Support$134.68
Latest news & SEC filings
No headlines in the last 90 days.
· Healthcare
SEPT Low Target
$114.75
SEPT Mid Target
$135.00
SEPT High Target
$155.25
Analyst Consensus
$135.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for APGE.
Start Free Trial →Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$119.88
17
Moat Score
NONE
3/9
Piotroski Score
147.0
Altman Z-Score
Insider Signal
SELLING
0 buys / 10 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
LOW
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| McKenna Mark C. | director | Sale | 20,000 | - | Sep 3, 2026 |
| JONES WILLIAM A JR | director | Sale | 34,824 | - | Sep 3, 2026 |
| Fox Jennifer A. | director | Sale | 34,824 | - | Sep 3, 2026 |
| Henderson Jane | officer | Sale | 158,371 | - | Sep 3, 2026 |
| HENDERSON MICHAEL THOMAS | director officer | Sale | 920,941 | - | Sep 3, 2026 |
| Shah Nimish P | director | Sale | 1,750,000 | $236.4M | Sep 3, 2026 |
| Fairmount Funds Management LLC | director | Sale | 340,855 | - | Sep 3, 2026 |
| Fairmount Funds Management LLC | director | Sale | 51,166 | - | Sep 3, 2026 |
| HENDERSON MICHAEL THOMAS | director officer | Sale | 75,046 | - | Jul 10, 2026 |
| HENDERSON MICHAEL THOMAS | director officer | Sale | 20,000 | $2.7M | Jul 8, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-27.88%
FCF Growth YoY
-35.0%
Revenue Trend
UNKNOWN
SEPT Investing tracks real-time dark pool institutional trades for APGE, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:17:37 | $135.10 | 1,200 | $$162K | SELL |
| 21:39:42 | $135.07 | 165,200 | $$22.3M | SELL |
| 20:59:14 | $135.07 | 23,366 | $$3.2M | SELL |
| 20:05:42 | $135.07 | 21,842 | $$3.0M | SELL |
| 20:05:29 | $135.07 | 11,620 | $$1.6M | SELL |
5 dark pool trades shown · $$30.2M preview volume
Real-time institutional flow, block trades, and net positioning
SEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for APGE. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Zone Setup — $APGE (Apogee Therapeutics, Inc.) Price: $135.07 | Zone: $135.06 — $135.09 Conviction: HIGH | Analyst upside: +-0.1% Major volume event today — setup forming. Earnings: EPS_BEAT. Earnin...
Smart Money Moves $NMAX — CONYERS INVESTMENTS LLC | Sale $549K $GCMG — SULLIVAN KATHLEEN PATRICIA | Sale $198K $KNSA — Megna Michael R | Sale $369K $APGE — McKenna Mark C. | Sale $APGE — JONES WILLIA...
Join 3,500+ traders discussing APGE in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
SEPT's Trading AI has generated a free, downloadable PDF research report for Apogee Therapeutics, Inc. (APGE) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Apogee Therapeutics, Inc. (APGE) is at $135.07, down 0.01% (-$0.01) at the Sep 2, 2026 close.
The average analyst price target for APGE is $135.00, ranging from $135 to $140, based on 9 analysts. Latest: Truist Securities maintains on Aug 13, 2026.
Analyst ratings for APGE: 0 Buy, 8 Hold, 8 Sell — consensus Hold.
APGE last reported on Aug 10, 2026: EPS -$1.14 vs -$1.07 expected — a miss of 6.5%.
APGE does not currently pay a dividend.
Support: $134.88, $134.68, $134.40.
Insider activity: SELLING, 0 buys and 10 sells in the last 90 days.